Search research articles
Contact Us
Filters
Showing results (81-90 of 120) with videos related to
Page
of 12
Sort By:
Blood
|
June 5, 2008
Anti-CD38 antibody-mediated clearance of human repopulating cells masks the heterogeneity of leukemia-initiating cells
David C Taussig, Farideh Miraki-Moud, Fernando Anjos-Afonso, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 12, 2006
Bortezomib therapy in patients with relapsed or refractory lymphoma: potential correlation of in vitro sensitivity and tumor necrosis factor alpha response with clinical activity
Sandra J Strauss, Lenushka Maharaj, Susan Hoare, et al.
Blood
|
November 19, 2008
Long-term outcomes to fludarabine and rituximab in Waldenström macroglobulinemia
Steven P Treon, Andrew R Branagan, Leukothea Ioakimidis, et al.
The New England Journal of Medicine
|
April 23, 2015
Results of a trial of PET-directed therapy for early-stage Hodgkin's lymphoma
John Radford, Tim Illidge, Nicholas Counsell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 26, 2006
Multicenter phase II trial of immunotherapy with the humanized anti-CD22 antibody, epratuzumab, in combination with rituximab, in refractory or recurrent non-Hodgkin's lymphoma
Sandra J Strauss, Frank Morschhauser, Juergen Rech, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 15, 2011
From libraries to candidate: the discovery of new ultra long-acting dibasic β₂-adrenoceptor agonists
Lilian Alcaraz, Andrew Bailey, Elaine Cadogan, et al.
Communications Chemistry
|
April 9, 2025
Factors affecting irreversible inhibition of EGFR and influence of chirality on covalent binding
Pasquale A Morese, Ayaz Ahmad, Mathew P Martin, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 7, 2020
Development of autotaxin inhibitors: A series of tetrazole cinnamides
Christopher G Thomson, Darren Le Grand, Mark Dowling, et al.
Communications Chemistry
|
May 19, 2025
Author Correction: Factors affecting irreversible inhibition of EGFR and influence of chirality on covalent binding
Pasquale A Morese, Ayaz Ahmad, Mathew P Martin, et al.
Blood
|
July 2, 2008
CNS Hodgkin lymphoma
Elizabeth R Gerstner, Lauren E Abrey, David Schiff, et al.
Page
of 12
Search research articles
Search
Showing results (81-90 of 120) with videos related to
Sort By:
Page
of 12
Blood
|
June 5, 2008
Anti-CD38 antibody-mediated clearance of human repopulating cells masks the heterogeneity of leukemia-initiating cells
David C Taussig, Farideh Miraki-Moud, Fernando Anjos-Afonso, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 12, 2006
Bortezomib therapy in patients with relapsed or refractory lymphoma: potential correlation of in vitro sensitivity and tumor necrosis factor alpha response with clinical activity
Sandra J Strauss, Lenushka Maharaj, Susan Hoare, et al.
Blood
|
November 19, 2008
Long-term outcomes to fludarabine and rituximab in Waldenström macroglobulinemia
Steven P Treon, Andrew R Branagan, Leukothea Ioakimidis, et al.
The New England Journal of Medicine
|
April 23, 2015
Results of a trial of PET-directed therapy for early-stage Hodgkin's lymphoma
John Radford, Tim Illidge, Nicholas Counsell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 26, 2006
Multicenter phase II trial of immunotherapy with the humanized anti-CD22 antibody, epratuzumab, in combination with rituximab, in refractory or recurrent non-Hodgkin's lymphoma
Sandra J Strauss, Frank Morschhauser, Juergen Rech, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 15, 2011
From libraries to candidate: the discovery of new ultra long-acting dibasic β₂-adrenoceptor agonists
Lilian Alcaraz, Andrew Bailey, Elaine Cadogan, et al.
Communications Chemistry
|
April 9, 2025
Factors affecting irreversible inhibition of EGFR and influence of chirality on covalent binding
Pasquale A Morese, Ayaz Ahmad, Mathew P Martin, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 7, 2020
Development of autotaxin inhibitors: A series of tetrazole cinnamides
Christopher G Thomson, Darren Le Grand, Mark Dowling, et al.
Communications Chemistry
|
May 19, 2025
Author Correction: Factors affecting irreversible inhibition of EGFR and influence of chirality on covalent binding
Pasquale A Morese, Ayaz Ahmad, Mathew P Martin, et al.
Blood
|
July 2, 2008
CNS Hodgkin lymphoma
Elizabeth R Gerstner, Lauren E Abrey, David Schiff, et al.
Page
of 12